GABELLI FUNDS LLC - JUNIPER PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$253,000
-30.5%
53,182
-18.2%
0.00%
-50.0%
Q4 2016$364,000
+0.8%
65,0000.0%0.00%0.0%
Q3 2016$361,000
-6.5%
65,000
+18.2%
0.00%0.0%
Q2 2016$386,000
+6.0%
55,0000.0%0.00%0.0%
Q1 2016$364,000
-35.8%
55,0000.0%0.00%
-33.3%
Q4 2015$567,000
+7.0%
55,000
+22.3%
0.00%0.0%
Q3 2015$530,000
-53.3%
44,954
-63.8%
0.00%
-50.0%
Q2 2015$1,135,000124,0960.01%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JW Asset Management, LLC 388,132$1,844,0000.38%
Krensavage Asset Management, LLC 243,128$1,155,0000.37%
ALGERT GLOBAL LLC 108,315$514,0000.14%
HEARTLAND ADVISORS INC 400,000$1,900,0000.12%
AWM Investment Company, Inc. 200,000$950,0000.09%
TFS CAPITAL LLC 31,619$150,0000.05%
GLOBEFLEX CAPITAL L P 20,012$95,0000.02%
Spark Investment Management LLC 45,100$214,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$856,0000.01%
Acrospire Investment Management LLC 1,605$8,0000.01%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders